摘要
目的:研究重组人肿瘤坏死因子受体融合蛋白(RhTNFR:Fc)对佐剂性关节炎(AA)大鼠模型的治疗作用及对巨噬细胞产生细胞因子的影响。方法:完全弗氏佐剂免疫SD大鼠诱导AA模型,随机分为正常组、模型组、RhTNFR:Fc低、中、高剂量组(1,3,9 mg.kg-1)和阴性对照组(IgG-Fc 9 mg.kg-1)。记录全身评分、关节炎指数、足爪肿胀度、关节肿胀数等整体评价指标、足爪X线摄片、踝关节病理检查及评分,ELISA试剂盒测定腹腔巨噬细胞(PMφ)上清中细胞因子白细胞介素1β(IL-1β),IL-6和肿瘤坏死因子α(TNF-α)水平。结果:RhTNFR:Fc给药组能不同程度地降低AA大鼠升高的全身评分、关节炎指数、足爪肿胀度和关节肿胀数等整体评价指标,减轻AA大鼠的关节炎症,改善AA大鼠X线摄片评分和关节病理学变化,下调PMφ的IL-1β,IL-6和TNF-α的分泌水平。结论:RhTNFR:Fc对大鼠AA的关节炎症具有治疗作用,且抑制腹腔巨噬细胞促炎性细胞因子的表达。
Objective: To investigate the effects of RhTNFR: Fc in an established adjuvant arthritis (AA) rat model and the effects on cytokines production of peritoneal macrophage (PMφ). Methods: AA was induced by complete Freund adjuvant. AA rats were randomly divided into different groups and then treated with RhTNFR:Fc (1, 3, 9 mg· kg^-1), or IgG-Fc (9 mg· kg^-1), respectively after immunization. Arthritis was evaluated by global assessment, polyarthritis index, hind paw swelling, swollen joint count, X-ray of the paws and histopathological examination and histopathological scores. Activities of interleukin-1 β(IL-1β) and interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in supernate of PMφ were assessed by ELISA. Results : Administration of RhTNFR : Fc significantly reduced the global assessment score, polyarthritis index, hind paw swelling and swollen joint count, a- meliorated X-ray and histopathological manifestations, and decreased the expressions of IL-1β, IL-6 and TNF-α. Conclusion: Data presented here demonstrate that administration of RhTNFR:Fc significantly attenuates progression of experimental arthritis, and reduces proinflammatory cytokines of PMφ.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2013年第5期524-530,共7页
Chinese Journal of New Drugs
基金
国家自然科学基金(30973543,31100640,81173075)
安徽省自然科学基金(11040606M195)
安徽省高等学校省级自然科学基金(KJ2010B398)